MOTS C UK: Science, Testing and UK Peptides Law
MOTS C UK Explained: The Mitochondrial Peptide Researchers Are Watching
MOTS-c is a tiny peptide with an unusually grand origin story. Rather than being encoded in the cell nucleus, it comes from mitochondrial DNA. That makes it a fascinating subject for researchers studying how cells respond to stress, exercise and changing energy demands.
What Is MOTS-c?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c. It is a 16-residue peptide encoded within the human mitochondrial genome. Its discovery was reported in Cell Metabolism in 2015 by a research team led by scientists at the University of Southern California. 1
Mitochondria are often introduced as the cell’s power stations. That description is useful, but incomplete. Modern research increasingly presents them as active signalling centres that communicate with the rest of the cell.
MOTS-c is part of that more sophisticated picture. Experimental work suggests that it can move beyond the mitochondria and participate in cellular responses to metabolic stress. 2
In plain English: MOTS-c is a short molecular message linked to the mitochondria. Researchers are investigating whether it helps cells adjust when energy conditions change.
Why Its Origin Is So Unusual
Most proteins and peptides discussed in human biology are encoded by nuclear DNA. MOTS-c is different because its sequence comes from a short open reading frame within mitochondrial DNA.
UniProt records the human MOTS-c entry as a 16-residue mitochondrial-derived peptide. PubChem also provides a dedicated chemical record for the human sequence. 3 4
The intriguing point is not merely that mitochondria generate energy. It is that they may also send molecular instructions about how a cell should respond.
Interactive MOTS-c Molecule Explorer
Select a residue to see its position and chemical character. The diagram shows the primary amino-acid sequence, not a confirmed three-dimensional structure.
Human MOTS-c sequence: MRWQEMGYIFYPRKLR. Select any circle for an explanation.
Select one of the 16 amino-acid circles above.
How Do Researchers Think MOTS-c Works?
The proposed pathway is still being refined. The steps below summarise the main experimental model without turning it into a treatment claim.
Metabolic Stress
Cells encounter a change in energy availability or another metabolic challenge.
Mitochondrial Signal
MOTS-c is studied as one of the signals associated with mitochondrial communication.
AMPK-Linked Response
Experimental studies connect MOTS-c with AMPK-dependent stress-response pathways.
Nuclear Gene Regulation
Under stress conditions, MOTS-c has been observed moving to the nucleus in cell research.
The Nuclear Translocation Finding
A 2018 study reported that MOTS-c can translocate to the cell nucleus during metabolic stress and influence nuclear gene expression through an AMPK-dependent process. 2
That finding is scientifically interesting because it adds a direct route through which a mitochondrially encoded peptide may communicate with nuclear machinery.
The MOTS-c Evidence, Properly Graded
Not all findings carry the same weight. Use the tabs to move from basic identity evidence to regulatory status.
Molecular identity
The human peptide is recorded as a 16-residue sequence. This establishes what MOTS-c is chemically. It does not establish a clinical benefit.
What the Research Does Show
Metabolic Homeostasis in Models
The original 2015 paper reported effects in cell and mouse models, including changes related to metabolic homeostasis. These were preclinical findings. 1
Movement to the Nucleus
Researchers observed MOTS-c entering the nucleus under metabolic stress and influencing gene expression in cell experiments. 2
Exercise-Responsive Biology
A 2021 study reported exercise-linked changes in endogenous MOTS-c in humans and performance-related findings in mice. 5
Age-Related Associations
Research in healthy men reported age-related differences in circulating and skeletal-muscle MOTS-c. Observational associations do not prove that administering the peptide changes ageing. 6
What the Research Does Not Yet Establish
- A generally accepted clinical indication for MOTS-c in the UK
- A complete human safety profile for independently sold research material
- Equivalence between a commercial vial and the material used in a published study
- That an external MOTS-c product reproduces the effects of naturally produced MOTS-c
- That a high HPLC percentage proves pharmaceutical quality, sterility or suitability for administration
University Research Behind the MOTS-c Story
The subject has moved from a surprising genetic discovery into a wider programme of mitochondrial and cellular-signalling research.
The Discovery Programme
Researchers linked to the USC Leonard Davis School of Gerontology helped identify and characterise MOTS-c. USC has since highlighted work on mitochondrial microproteins, metabolism, immunity and age-related biology. 7
Exercise and Ageing Research
The exercise-related publication involved researchers examining human responses alongside controlled mouse experiments. The human component concerned endogenous MOTS-c, not an online research product. 5
Mechanistic Reviews
Peer-reviewed reviews describe MOTS-c as a mitochondrial-derived peptide involved in stress-response and metabolic pathways, while repeatedly noting that clinical translation remains incomplete. 8
A Promising Subject Is Not an Approved Therapy
The most polished reading of the literature keeps excitement and evidence in proportion. Mechanistic promise is the beginning of a research story, not the final regulatory conclusion.
MOTS-c Compared with Other Popular Research Compounds
Similar catalogue placement does not mean similar chemistry. These comparisons help readers avoid easy naming mistakes.
| Material | What it is | General research context | Important distinction |
|---|---|---|---|
| MOTS-c | 16-residue mitochondrial-derived peptide | Mitochondrial signalling, stress response and metabolism | Encoded within mitochondrial DNA |
| Humanin | Another mitochondrial-derived peptide | Cell-survival and stress-response research | Different sequence and biological research history |
| SS-31 | Synthetic tetrapeptide, also known as elamipretide | Mitochondrial membrane and cardiolipin research | Not encoded as MOTS-c and structurally unrelated |
| AICAR | Ribonucleoside-related small molecule | AMPK-linked metabolic research | Not a peptide |
| 5-Amino-1MQ | Synthetic small molecule | NNMT-related laboratory research | Not an amino-acid peptide despite catalogue placement |
| GHK-Cu | Copper complex involving a tripeptide | Copper-peptide and tissue-model research | Requires copper-composition questions as well as peptide testing |
How Is MOTS-c Checked in a Laboratory?
A responsible analytical record should address identity, purity and quantity as separate questions.
HPLC or UHPLC
Chromatography can separate detectable components under a defined method and report the relative area of the main peak.
Mass Spectrometry
Mass analysis can help determine whether the observed material is consistent with the expected molecular mass of MOTS-c.
Peptide Mapping or Tandem MS
Fragmentation methods can provide stronger evidence that the amino acids appear in the expected order.
Net Peptide Assay
The amount of MOTS-c should be distinguished from total dried material, water, counterions and residual substances.
Why 99% HPLC Is Not the Whole Story
A 99% HPLC result usually describes the proportion of detected chromatographic peak area assigned to the main peak under one method.
- It does not automatically prove that the main peak is MOTS-c
- It does not establish that all 16 residues are in the correct order
- It does not establish the net quantity of peptide in the vial
- It does not establish sterility, endotoxin level or microbial quality
- It does not show that the material matches a university study batch
- It does not establish suitability for human or animal administration
How to Compare MOTS-c Research Suppliers in the UK
The most persuasive supplier page is not the one with the boldest promise. It is the one with the clearest, batch-specific evidence.
Legal Business Identity
Look for a traceable company name, address, contact route and clear terms.
Complete Product Identity
The listing should state MOTS-c and the full 16-residue sequence.
Matching Batch Number
The vial, invoice and analytical report should refer to the same lot.
Identity Plus Purity Testing
A chromatographic result is stronger when supported by suitable molecular identity evidence.
Raw Analytical Information
Chromatograms, spectra, method details and analysis dates add useful context.
Clear Quantity Basis
The supplier should explain whether the stated amount is net peptide or total dried material.
Product-Specific Storage
Technical storage information should relate to the exact material and remain laboratory focused.
No Personal-Use Marketing
A research supplier should not provide cycles, injections, transformation claims or personal outcome reviews.
Red Flags
- One generic certificate reused across several batches
- A certificate with no issuing laboratory or test date
- Claims of pharmaceutical grade based only on HPLC purity
- Exercise, ageing, weight or metabolic promises aimed at consumers
- Before-and-after photographs or dosage calculators
- A Research Use Only notice contradicted by the rest of the page
MOTS-c, UK Law and Anti-Doping Rules
Legal status depends on the actual product, claims, intended purpose and complete presentation. A label alone does not settle the matter.
Medicines Classification
The MHRA determines whether a product falls within the legal definition of a medicinal product. Its assessment can consider composition, pharmacological properties, express claims, implied claims, format, imagery and the way the product is presented to the public. 9
Regulation 279 of the Human Medicines Regulations restricts advertising a medicinal product where the required authorisation, registration or certificate is not in force. 10
No current UK marketing authorisation for a MOTS-c medicinal product was identified in the official sources checked for this article on 18 July 2026.
Research Use Only Is Not a Universal Exemption
Research Use Only can accurately describe a laboratory material. It does not neutralise consumer-facing claims about treatment, body composition, exercise, ageing or personal outcomes elsewhere on a website.
WADA Status
MOTS-c is named on the World Anti-Doping Agency’s 2026 Prohibited List. The list came into effect on 1 January 2026. 11
Anti-doping status is separate from analytical purity and UK product classification. A Certificate of Analysis does not create an exemption for an athlete.
Continue Reading with It’s Me & You Clinic
For a companion article focused on molecular identity, research interpretation and UK peptide terminology, visit the clinic’s dedicated MOTS-c guide.
Read the MOTS-c UK guideResearch Peptides UK Advisory Board
This article has been prepared for expert review. Change the titles below to “Reviewed by” only after each named person has approved this exact version in writing.
Dr Laura Geige
Prepared for Clinical Editorial Review
Proposed review of medical wording, public clarity and the separation of laboratory evidence from personal advice.
Professional biographyDr Snieguole Geige
Prepared for Evidence Review
Proposed review of evidence levels and the difference between cell, animal, observational and clinical findings.
Professional biographyDr Rimas Geiga
Prepared for Scientific Review
Proposed review of mitochondrial terminology, AMPK-linked signalling and responsible interpretation of experimental research.
Professional biographyLivija Samušienė
Prepared for Scientific Terminology Review
Proposed review of peptide naming, analytical terminology and accessible explanation of molecular structure.
Professional biographyFrequently Asked Questions About MOTS C UK
Clear answers to the questions readers most often encounter.
What is MOTS-c?
MOTS-c is a 16-residue mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region.
What is the MOTS-c amino-acid sequence?
The human sequence is MRWQEMGYIFYPRKLR.
Why is MOTS-c called mitochondrial-derived?
Its genetic instructions come from a short reading frame within mitochondrial DNA rather than the nuclear genome.
Does MOTS-c move to the cell nucleus?
Cell research has reported nuclear translocation during metabolic stress. This is a mechanistic laboratory finding rather than proof of a clinical outcome.
Was MOTS-c discovered at a university?
The 2015 discovery paper involved researchers associated with the University of Southern California and international collaborators.
Has MOTS-c been studied in humans?
Human studies have examined naturally occurring MOTS-c levels and exercise-linked responses. That is different from establishing the safety or effectiveness of an independently sold external product.
Is MOTS-c an approved UK medicine?
No current UK marketing authorisation for a MOTS-c medicinal product was identified in the official sources checked for this article.
Is MOTS-c prohibited in sport?
Yes. MOTS-c is named on the 2026 WADA Prohibited List.
Does 99% HPLC prove that a sample is MOTS-c?
Not by itself. HPLC supplies chromatographic information. Molecular identity requires suitable supporting analysis.
Does a COA prove that a vial is safe?
No. A COA reports only the tests stated on the document. It does not automatically establish sterility, endotoxin level, clinical safety or suitability for administration.
Is MOTS-c the same as Humanin?
No. Both are mitochondrial-derived peptides, but they have different sequences and research histories.
Is MOTS-c the same as SS-31?
No. SS-31 is a separate synthetic tetrapeptide associated with mitochondrial membrane research.
Scientific and Official Sources
- Lee and colleagues, Cell Metabolism: discovery and early characterisation of MOTS-c
- Kim and colleagues: MOTS-c nuclear translocation and gene regulation during metabolic stress
- UniProt: human mitochondrial-derived peptide MOTS-c
- PubChem: human MOTS-c chemical record
- Reynolds and colleagues: exercise-linked MOTS-c research in humans and mice
- D’Souza and colleagues: circulating and skeletal-muscle MOTS-c across age groups
- University of Southern California: mitochondrial microprotein research
- Review of MOTS-c research, mechanisms and translational limits
- MHRA: Borderline products and how to tell if a product is a medicine
- Human Medicines Regulations 2012, Regulation 279
- World Anti-Doping Agency: 2026 Prohibited List
- USADA: What is the MOTS-c peptide?
